Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099005 · ClinicalTrials.gov registry record · Phase 2
Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain
A Phase 2 study of Cannabis and Pain Syndrome, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03099005 is a Phase 2 study of Cannabis and Pain Syndrome that has completed, run by University of California, San Diego. The registered enrollment target is 5 participants, below the 111-participant average among 24 other Cannabis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03099005, a Phase 2 study of Cannabis and Pain Syndrome, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute cannabis administration is reported to alleviate HIV neuropathic pain (HIV-NP), but there is limited knowledge about the effects of cannabis constituents (delta-9 tetrahydrocannabinol/THC and cannabidiol/CBD), the consequences of long-term cannabis use, and the impact of cannabis on endocannabinoid (EC) function in people living with HIV- NP. Our objective is to address these three fundamental gaps in our knowledge by: 1) examining the acute effects of various CBD/THC products on HIV-NP, 2) utilizing a mHealth text messaging protocol, Individual Monitoring of Pain and Cannabis Taken (IMPACT) to monitor daily real-world cannabis use and changes in pain; and 3) studying the relationship between cannabinoids, EC biomarkers, and chronic neuropathic pain
Conditions Studied
Interventions
- DRUG Cannabis
Study Locations (1)
California
- UC Center for Medicinal Cannabis Research, UC San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03099005
The ClinicalTrials.gov registry entry for NCT03099005 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 24 other Cannabis trials with a reported enrollment target (95% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which Cannabis is the first listed.
NCT03099005 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03099005 about?
NCT03099005 is a clinical study titled "Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain". Acute cannabis administration is reported to alleviate HIV neuropathic pain (HIV-NP), but there is limited knowledge about the effects of cannabis constituents (delta-9 tetrahydrocannabinol/THC and cannabidiol/CBD), the consequences of long-term cannabis use, and the impact of cannabis on endocannab...
What is the current status of trial NCT03099005?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2018-07-01. Estimated completion is 2022-12-31.
What conditions does trial NCT03099005 study?
This clinical trial studies the following conditions: Cannabis, Pain Syndrome, HIV Neuropathy.
What interventions are being tested in trial NCT03099005?
The interventions under investigation include: Cannabis (DRUG).
Who is sponsoring clinical trial NCT03099005?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03099005 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
RECRUITING · Phase 2
-
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
RECRUITING · Phase 2
-
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
COMPLETED · Phase 2
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
RECRUITING · Phase 1
-
Cannabis, HIV and Mental Processing Systems
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.